Physician profile
Nathan D Brown
NPI 1609221696
$3,688.82
in general payments reported to CMS, 2019-2025
45 companies · $928 in 2025
The $928 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $687 · 2023: $893 · 2024: $957 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.43 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.60 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $369.68 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $273.68 | 2022-2024 | Prolia, Evenity, Otezla |
| Pfizer INC. | $272.52 | 2022-2025 | |
| Glaxosmithkline, LLC. | $251.84 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $237.25 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Astellas Pharma US INC | $120.54 | 2024-2025 | Veozah |
| Viiv Healthcare Company | $96.23 | 2023-2024 | Apretude |
| Sanofi-Aventis U.S. LLC | $86.26 | 2021-2025 | |
| Organon LLC | $84.92 | 2022-2025 | Nexplanon, Nuvaring |
| Janssen Pharmaceuticals, INC | $82.74 | 2021-2024 | Spravato |
| Dynavax Technologies Corporation | $76.58 | 2022-2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $73.19 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Currax Pharmaceuticals LLC | $65.60 | 2022-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.27 | 2022-2023 | Jardiance, Synjardy |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.